1
TITLE: The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark
AUTHORS: Ehlers, LH; Lamotte, M; Ramos, MC; Sandgaard, S; Holmgaard, P; Frary, EC; Ejskjaer, N;
PUBLISHED: 2021, SOURCE: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, VOLUME: 11, ISSUE: 1
INDEXED IN: Scopus WOS